BLOG main image
분류 전체보기 (168)
FreeBSD (1)
Stock (33)
ThinkPad, etc. (27)
Drama, Movies, etc. (42)
FDA Approvals (25)
Books (40)
Visitors up to today!
Today hit, Yesterday hit
daisy rss
tistory 티스토리 가입하기!
2015. 2. 28. 17:48

[2015-Jan-29] HIV/AIDS Update - Prezcobix tablet containing 800 mg of darunavir and 150 mg of cobicistat approval

http://content.govdelivery.com/accounts/USFDA/bulletins/ed4466




Prezcobix.cdx

Arun K Ghosh, John F Kincaid, Wonhwa Cho, D.Eric Walters, K Krishnan, Khaja Azhar Hussain, Yumee Koo, Hanna Cho, Clare Rudall, Louis Holland and Jim Buthod, Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere, Bioorg. Med. Chem. Lett., 1998, 8 (6), pp 687-690

http://dx.doi.org/10.1016/S0960-894X(98)00098-5


Sandra De Meyer, Hilde Azijn, Dominique Surleraux, Dirk Jochmans, Abdellah Tahri, Rudi Pauwels, Piet Wigerinck and Marie-Pierre de Béthune, TMC114, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor Active against Protease Inhibitor-Resistant Viruses, Including a Broad Range of Clinical Isolates, Antimicrob. Agents Chemother.200549 (6), pp 2314-2321

http://dx.doi.org/10.1128/AAC.49.6.2314-2321.2005


Bonaventura Clotet, Nicholas Bellos,Jean-Michel Molina, David Cooper, Jean-Christophe Goff ard, Adriano Lazzarin, Andrej Wöhrmann, Christine Katlama, Timothy Wilkin, Richard Haubrich, Calvin Cohen, Charles Farthing, Dushyantha Jayaweera, Martin Markowitz, Peter Ruane, Sabrina Spinosa-Guzman, Eric Lefebvre,on behalf of the POWER 1 and 2 study groups, Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials, Lancet, 2007369 (9568), pp 1169-1178

http://dx.doi.org/10.1016/S0140-6736(07)60497-8


Lianhong Xu, Hongtao Liu, Bernard P. Murray, Christian Callebaut, Melody S. Lee, Allen Hong, Robert G. Strickley, Luong K. Tsai, Kirsten M. Stray, Yujin Wang, Gerry R. Rhodes and Manoj C. Desai, Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer, ACS Med. Chem. Lett., 2010, 1 (5), pp 209–213

http://dx.doi.org/10.1021/ml1000257


Eve-Irene Lepist, Truc K. Phan, Anupma Roy, Leah Tong, Kelly MacLennan, Bernard Murray and Adrian S. Ray, Cobicistat Boosts the Intestinal Absorption of Transport Substrates, Including HIV Protease Inhibitors and GS-7340, In Vitro, Antimicrob. Agents Chemother., 2012, 56 (10), pp 5409-5413

http://dx.doi.org/10.1128/AAC.01089-12